Search - tctmd.com

Displaying 1 - 20 of 152

Sort: Relevancy | Date

Presentation TCT 2016

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results

Presenter: Gary S. Mintz, Robert-Jan van Geuns, Fernando Alfonso

November 02, 2016

Presentation TCT 2016

ReACT: A Prospective, Randomized Trial of Routine Angiographic Follow-up After Coronary Artery Stent Implantation

Presenter: Howard C. Herrmann, Robert J. de Winter, Hiroki Shiomi

November 01, 2016

Presentation TCT 2016

Physiological Testing of Coronary Artery Stenosis by Computation of Invasive Coronary Angiography. The Wire-Free Functional Imaging (WIFI-II) Study

Presenter: Fernando Alfonso, Ran Kornowski, Jelmer Westra

November 01, 2016

Presentation TCT 2016

TCT 12: Real-world Utilization of Computed Tomography Derived Fractional Flow Reserve: Single Center Initial Experience in the United States

Presenter: Daniel S. Berman, Pamela S. Douglas, Anas Fares

October 31, 2016

Presentation TCT 2016

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Bo Xu

October 31, 2016

Presentation TCT 2016

TCT 11: Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary X-ray Angiography in the International Multicenter FAVOR (Functional Assessment by Various FlOw Reconstructions) Pilot Study

Presenter: Daniel S. Berman, Pamela S. Douglas, Shengxian Tu

October 31, 2016

Presentation TCT 2016

FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Antonio Colombo

October 31, 2016

Presentation TCT 2016

MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Ashok Seth

October 31, 2016

Presentation TCT 2016

TCT 10: Physiological Testing of Coronary Artery Stenosis by Computation of Invasive Coronary Angiography. The Wire-Free Functional Imaging (WIFI-II) Study

Presenter: Daniel S. Berman, Pamela S. Douglas, Jelmer Westra

October 31, 2016

Presentation TCT 2016

FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Alexandre Abizaid

October 31, 2016

Presentation TCT 2016

TCT 9: A Per-Vessel Level Systematic Review of Computed Tomography-Derived FFR (FFR-CT) Diagnostic Accuracy Studies: Implications for Clinical Decision-making

Presenter: Daniel S. Berman, Pamela S. Douglas, Justin E. Davies

October 31, 2016

Presentation TCT 2016

REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Stephen G. Worthley

October 31, 2016

Presentation TCT 2016

TCT 118: Sex Differences in Coronary Angiography, Percutaneous Coronary Intervention, and Outcomes During Hospitalization After Out of Hospital Cardiac Arrest with Ventricular Fibrillation or Pulseless Ventricular Tachycardia

Presenter: Michel R. Le May, Ivan C. Rokos

October 31, 2016

Presentation TCT 2016

Left Main Stenting: Fascinating Cases and Lessons From the EXCEL Angiographic Core Lab

Presenter: David E. Kandzari, Jens Flensted Lassen, Philippe Généreux

October 30, 2016

Presentation TCT 2016

Coronary Angiography: Set-up, Views, Artifacts, and Pitfalls

Presenter: George D. Dangas, Vijay Kunadian, Philippe Généreux

October 29, 2016

Presentation Stanford Coronary Physiology Conference 2016

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

Presenter: William F. Fearon

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

FFR-Guided PCI Vs Medical Therapy: FAME 2 and Substudies

Presenter: Bernard De Bruyne

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

Assessing Chest Pain and Non-obstructive CAD

Presenter: Jennifer A. Tremmel

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

FFR in Multivessel Disease: FAME-1 and Substudies

Presenter: Nico H. J. Pijls

October 28, 2016

Presentation ESC 2016

CE-MARC 2 Trial: A Prospective, Multi-Centre, Randomized Trial Of 3 Diagnostic Strategies In Suspected Coronary Heart Disease (CMR vs UK NICE Guidelines vs MPS-SPECT)

Presenter: John P. Greenwood

August 29, 2016

Advertisement

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results

ReACT: A Prospective, Randomized Trial of Routine Angiographic Follow-up After Coronary Artery Stent Implantation

Physiological Testing of Coronary Artery Stenosis by Computation of Invasive Coronary Angiography. The Wire-Free Functional Imaging (WIFI-II) Study

TCT 12: Real-world Utilization of Computed Tomography Derived Fractional Flow Reserve: Single Center Initial Experience in the United States

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

TCT 11: Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary X-ray Angiography in the International Multicenter FAVOR (Functional Assessment by Various FlOw Reconstructions) Pilot Study

FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

TCT 10: Physiological Testing of Coronary Artery Stenosis by Computation of Invasive Coronary Angiography. The Wire-Free Functional Imaging (WIFI-II) Study

FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

TCT 9: A Per-Vessel Level Systematic Review of Computed Tomography-Derived FFR (FFR-CT) Diagnostic Accuracy Studies: Implications for Clinical Decision-making

REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent

TCT 118: Sex Differences in Coronary Angiography, Percutaneous Coronary Intervention, and Outcomes During Hospitalization After Out of Hospital Cardiac Arrest with Ventricular Fibrillation or Pulseless Ventricular Tachycardia

Left Main Stenting: Fascinating Cases and Lessons From the EXCEL Angiographic Core Lab

Coronary Angiography: Set-up, Views, Artifacts, and Pitfalls

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

FFR-Guided PCI Vs Medical Therapy: FAME 2 and Substudies

Assessing Chest Pain and Non-obstructive CAD

FFR in Multivessel Disease: FAME-1 and Substudies

CE-MARC 2 Trial: A Prospective, Multi-Centre, Randomized Trial Of 3 Diagnostic Strategies In Suspected Coronary Heart Disease (CMR vs UK NICE Guidelines vs MPS-SPECT)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content